A detailed history of Ifp Advisors, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 58 shares of CRL stock, worth $11,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58
Previous 7 728.57%
Holding current value
$11,354
Previous $1,000 1000.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$206.39 - $268.73 $10,525 - $13,705
51 Added 728.57%
58 $11,000
Q1 2024

Jul 30, 2024

BUY
$203.52 - $273.43 $1,017 - $1,367
5 Added 250.0%
7 $1,000
Q4 2023

Jan 09, 2024

SELL
$164.52 - $238.84 $8,884 - $12,897
-54 Reduced 96.43%
2 $0
Q3 2023

Oct 12, 2023

BUY
$194.44 - $217.61 $8,360 - $9,357
43 Added 330.77%
56 $10,000
Q2 2023

Aug 04, 2023

BUY
$183.71 - $210.25 $1,285 - $1,471
7 Added 116.67%
13 $2,000
Q1 2023

Apr 18, 2023

SELL
$191.89 - $259.92 $67,353 - $91,231
-351 Reduced 98.32%
6 $1,000
Q4 2022

Feb 07, 2023

SELL
$197.11 - $250.07 $474,049 - $601,418
-2,405 Reduced 87.07%
357 $48,000
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $17,514 - $24,051
96 Added 3.6%
2,762 $329,000
Q2 2022

Sep 06, 2022

BUY
$204.13 - $302.4 $544,210 - $806,198
2,666 New
2,666 $314,000
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $544,210 - $806,198
-2,666 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$255.51 - $362.11 $339,317 - $480,882
1,328 Added 99.25%
2,666 $757,000
Q1 2022

Aug 08, 2022

BUY
$255.51 - $362.11 $213,095 - $301,999
834 Added 165.48%
1,338 $379,000
Q4 2021

Jan 12, 2022

SELL
$351.38 - $448.68 $47,787 - $61,020
-136 Reduced 21.25%
504 $190,000
Q3 2021

Oct 06, 2021

SELL
$372.64 - $458.3 $12,297 - $15,123
-33 Reduced 4.9%
640 $264,000
Q2 2021

Jul 13, 2021

BUY
$294.17 - $371.65 $6,177 - $7,804
21 Added 3.22%
673 $247,000
Q1 2021

Apr 30, 2021

BUY
$249.67 - $299.48 $9,986 - $11,979
40 Added 6.54%
652 $192,000
Q4 2020

Jan 25, 2021

BUY
$222.0 - $252.62 $55,500 - $63,155
250 Added 69.06%
612 $150,000
Q3 2020

Oct 29, 2020

SELL
$175.56 - $226.45 $4,389 - $5,661
-25 Reduced 6.46%
362 $80,000
Q2 2020

Aug 05, 2020

BUY
$118.84 - $189.72 $713 - $1,138
6 Added 1.57%
387 $65,000
Q1 2020

May 12, 2020

BUY
$98.9 - $178.34 $10,384 - $18,725
105 Added 38.04%
381 $49,000
Q4 2019

Jan 17, 2020

BUY
$126.05 - $152.76 $3,907 - $4,735
31 Added 12.65%
276 $41,000
Q3 2019

Nov 07, 2019

BUY
$125.07 - $143.67 $30,642 - $35,199
245 New
245 $31,000
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $16,142 - $22,596
-154 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$105.09 - $137.23 $6,935 - $9,057
66 Added 75.0%
154 $17,000
Q3 2018

Oct 25, 2018

BUY
$112.11 - $134.54 $1,345 - $1,614
12 Added 15.79%
88 $0
Q2 2018

Aug 07, 2018

BUY
$102.37 - $117.25 $2,456 - $2,814
24 Added 46.15%
76 $0
Q4 2017

Jan 24, 2018

SELL
$100.43 - $118.09 $50,215 - $59,045
-500 Reduced 90.58%
52 $0
Q3 2017

Oct 30, 2017

BUY
$96.72 - $109.26 $4,642 - $5,244
48 Added 9.52%
552 $60,000
Q4 2016

Jun 03, 2019

SELL
N/A
-44 Reduced 8.03%
504 $38,000
Q2 2016

Jun 03, 2019

BUY
N/A
548
548 $45,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.